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ABSTRACT  
OBJECTIVE: The objective of this selective evidence based medicine review is to determine 
whether or not “Do abdominal binders placed after cesarean delivery reduce postoperative pain?” 
 
STUDY DESIGN: Systematic review of three peer-reviewed studies written in English, 
published between the years 2016 and 2018.  
 
DATA SOURCES: All three studies are randomized controlled trials found using PubMed 
database, and they were the only existing RCTs evaluating this objective published at the onset 
of this review.  
 
OUTCOME MEASURED: The primary outcome measured in each study is self-reported pain 
on postoperative day 1 following cesarean delivery. Pain is measured on a scale from 0 to10 
using the Visual Analog Scale or as part of the Brief Pain Inventory- Short Form.  
 
RESULTS: Two of the three randomized controlled trials found significantly lower reported 
pain levels in the binder group. The study by Gustafson, Dong, Duong, and Kuhlmann (Kans J 
Med. 2018;11(2):48-53. PMID: 29796155) found significantly lower average level of pain at 24 
hours post-op (p= 0.024). The study by Ghana, Hakimi, Mirghafourvand, Abbasalizadeh, and 
Behnampour (Int J Gynecol Obstet. 2017;137(3):271-276. doi:10.1002/ijgo.12134) reports 
significantly lower pain scores (p<0.001) at all time points postoperatively, measured up to 5 
days. The third study did not find a significant difference in pain level on post-op day 1 (p=0.33) 
but cited the most weaknesses in experimental design (Gillier CM, Sparks JR, Kriner R, Anasti 
JN. Int J  Gynecol Obstet. 2016;133(2):188-191. doi:10.1016/j.ijgo.2015.08.026).   
 
CONCLUSIONS: Because two robust RCTs reported significantly lower postoperative pain 
levels in the binder group, and substantial limitations in the third study lessened the validity of 
those findings, this review finds stronger evidence to support using abdominal binders in 
multimodal reduction of post-cesarean pain.   
 
KEY WORDS: abdominal binder, cesarean, postoperative pain 
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INTRODUCTION  
 
 Multimodal approaches to effective pain management after cesarean delivery that 
minimize opioid use and postoperative adverse events are being extensively explored, including 
the use of abdominal binders.1 Abdominal binders are wide elastic belts that encircle the 
abdomen, providing flexible support to abdominal muscles and viscera at incision sites. 
Abdominal binders are commonly used and have been shown to improve mobility and 
ambulation distance; decrease the chance of wound dehiscence; and reduce discomfort 
associated with coughing, laughing, or positional changes following other major abdominal 
surgeries, such as ventral hernia repairs.2 Cesarean deliveries are the most common major 
surgery performed in the United States, totaling over 1.2 million and accounting for 32% of all 
births in 2017.3 Yet, binders are not routinely used after dividing all layers of the abdominal wall 
and incising the uterus in cesarean deliveries. Therapeutic standard of care for cesarean 
postoperative pain typically comprises of NSAIDs, acetaminophen, and/or opioids after relief 
from procedural anesthesia subsides.4 Abdominal binders may be a cost-effective, non-
pharmacologic adjunct to pain management for women who have had cesarean delivery. Non-
pharmacologic treatments for this population are desirable because breast-feeding ability, need 
for early post-op ambulation, and maternal alertness must be considered. Women undergoing this 
invasive operation have unique postoperative needs due to their hypercoagulable state and the 
immediate care and bonding required by the infant.5,6 
Physician assistants could easily employ the use of abdominal binders in the management 
of post-cesarean pain. Singular use of opioids for pain control following obstetric surgeries is 
positively correlated with increased cost, risk of opioid dependence, complications, and length of 
stay compared to multimodal approaches.7 Abdominal binders can be purchased online or as 
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conveniently as the local grocery store for fifteen to twenty-five dollars on average if not 
provided during hospitalization. Physician assistants in any field may care for women with 
upcoming or postoperative cesarean deliveries, and they have the clinical ability to write opioid 
prescriptions and recommend use of an abdominal binder. Therefore, physician assistants can 
play a critical role in implementing effective multimodal post-cesarean pain management. 
While the rates of cesareans continue to climb in high-income countries, the rates of 
breast feeding initiation are significantly lower when compared with vaginal deliveries.8 Several 
factors contribute to lower breast feeding rates after cesareans, including high levels of 
postoperative pain and limited mobility.8  Pain can inhibit the milk let-down reflex, and limited 
mobility can affect the mother’s ability to properly position the infant on the breast.9 While the 
current gold standard of post-cesarean analgesia is opioids, the adverse effects of sedation, 
nausea, and vomiting can also limit breastfeeding.10 Additionally, some new mothers would 
rather tolerate moderate pain than expose themselves or their breastfeeding infant to opioids, 
which do enter breast milk and pose health risks to the baby.9,10 Multimodal approaches are 
needed to adequately control pain while allowing for safe completion of maternal activities of 
daily living and early ambulation to reduce thromboembolism risk.9 Both pain and opioid-
induced sedation can inhibit ambulation, which is critical because postpartum women have at 
least a 5 times higher risk of thromboembolism.9 If abdominal binders can improve postoperative 
pain, then they could also reduce need for opioid use, facilitate early maternal ambulation to 
reduce thromboembolism risk, and improve breastfeeding rates to optimize infant nutrition.  
OBJECTIVE  
 
The objective of this selective evidence based medicine review is to determine whether or 
not “Do abdominal binders placed after cesarean delivery reduce postoperative pain?” 
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METHODS 
 
This paper evaluates three randomized controlled trials (RCTs) that assess the effect of 
abdominal binders on maternal post-cesarean pain levels when used in conjunction with standard 
therapy compared to standard therapy alone. All patients were allowed to request pain 
medication as needed within the limits of physician orders, but the control group was not given 
an opportunity to wear the abdominal binder. The population studied is women greater than 18 
years old that underwent cesarean sections; see Table 1 for specific inclusion and exclusion 
criteria of each study. There are slight variations between studies in regards to the onset and 
duration of abdominal binder use (Table 1) as well as specifically what constitutes standard 
therapy. Gillier et al.5 describes the standard of care as ibuprofen, acetaminophen, ketorolac, 
codeine plus acetaminophen, oxycodone plus acetaminophen, hydrocodone plus acetaminophen, 
and/or  morphine. Gustafson et al.6 uses ibuprofen, ketorolac, oxycodone, oxycodone plus 
acetaminophen, hydrocodone plus acetaminophen, nalbuphine, hydromorphone, and/or 
morphine. The Ghana et al.11 study does not specify which analgesics comprise the standard 
therapy. In each RCT, mothers self-reported numeric pain level (0-10) on postoperative day 1 
with zero representing no pain and 10 representing the most severe pain. The experimenters 
measured pain levels at variable times, but all three studies report an average measurement on 
postoperative day 1, so results at that specific time point will be compared in this review. The 
statistics used to evaluate this outcome are mean pain scores with standard deviation, median 
pain scores with interquartile range, and p-values to determine if there are significant differences 
(p <0.05) between groups’ average reported pain levels. 
This research question was investigated by the author using PubMed with the keywords 
“abdominal binder; cesarean OR caesarean; pain” to locate studies with relevant patient-oriented 
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outcomes. Additional inclusion criteria were controlled clinical trials or RCTs published within 
the last 10 years. The three selected articles for this review are all published in peer-reviewed 
journals and written in English. No reviews of the research question exist in the Cochrane 
Reviews Library at this time. Exclusion criteria were: disease-oriented outcomes, mothers 
younger than 18 years old, and studies published before 2008.  
TABLE 1- Demographics & Characteristics of Included Studies  
RCT # 
Pts 
Age:   
(Experimental/ 
Control)  
Inclusion Criteria Exclusion Criteria W/D Intervention 
Gillier et 
al.5 (2016) 
155 Range: 18-50 
E: 30.1 +/- 5          
C: 28 +/- 6.9  
Women who 
underwent cesarean 
delivery by a low-
transverse skin 





November 28, 2014.  
 
General anesthesia, vertical 












60 Range: 18-39 
E: 28.5+/- 4.7       
C: 27.7+/- 4.4  
Women from 2 
clinics in Kansas, 
USA that delivered 
via scheduled 
cesarean at term, 
singleton gestation, 
aged 18-39 years 
old, literate in 
English, and 
prenatal BMI of 20-
40 kg/m2  
Bleeding disorder or use of 
anticoagulants, methadone 
usage, abnormal placenta, 
preoperative hemoglobin 
less than 10mg/dL, 
chorioamnionitis, treated for 
chronic pain, onset of labor 
occurred prior to the time 
when the cesarean was 
scheduled, or complications 







and worn for 
24 hours 
Ghana et 
al.11 (2017)  
178  Range: 18-35 
Cumulative: 




in Iran between 
January 22- October 
23, 2015. Parity of 1 






>110 mg/L during 
first trimester.  
 
Smokers or using opioids, 
experienced rupture of 
membranes for longer than 
6 hours, self-reported 
underlying disease, surgical 
duration longer than 1 hour, 
had undergone any 
concurrent surgeries, had 
pre-eclampsia or eclampsia, 
severe hemorrhage, 
bleeding disorders or were 
using anticoagulants, 
emergency cesarean 
delivery, general anesthesia 
3 Abdominal 
binder applied 
2 hours after 
delivery and 






  Tuholski, Binders for Cesarean Pain  5 
OUTCOMES MEASURED  
 
Mothers self-reported their average numeric pain level on postoperative day 1 on a scale 
of 0-10 using the Visual Analog Scale (VAS) or as part of the Brief Pain Inventory- Short Form.  
RESULTS  
 
 In the study by Gillier et al.,5 180 women aged 18-50 were enrolled at a university 
hospital in Pennsylvania, USA, and the lead researchers assigned 92 participants to the 
experimental abdominal binder group and 88 to the control group.5 This study allowed for 
inclusion of emergency cesareans because women planning to undergo vaginal delivery 
consented to the study early in the pregnancy.5 Exclusion criteria were: general anesthesia, 
vertical incision, and the use of postoperative drains.5 Computer-generated 1:1 randomization 
was used to allocate participants into either group, and their designation was drawn from an 
opaque envelope upon entering the operating suite.5 No significant demographic differences or 
numbers of unscheduled cesareans existed between groups.5 Five individuals were not included 
in the final data for the experimental group; of these, one person requested removal of the binder 
within 6 hours.5 In the control group, 20 participants could not be included in final data because 
17 participants requested to receive an abdominal binder within 6 hours of surgery.5 The 
remaining unaccounted participants in each group had incomplete data collection.5 Patients in the 
abdominal binder group were fitted with the binder immediately after surgery before leaving the 
operating room and were encouraged not to remove it, but were allowed unmeasured breaks.5 
The primary outcome measured is postoperative pain recorded on day 1 using the VAS.5 Patients 
were asked to place a mark from 0-10 on a 10-cm line corresponding to the severity of their pain 
within the last 6 hours.5 The mean VAS score +/- standard deviation in the experimental group 
was 3.1 +/- 2.1 compared to 3.4 +/- 2.3 in the control group with an insignificant p-value of 0.33 
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(Table 2).5 Gillier and colleagues report the sample size offered an 80% power to detect a 1-cm 
difference in the VAS score between groups, which was deemed clinically approriate.5 
Table 2: Average VAS Pain Scores on Post-Op Day 1 in Gillier et al Study  




Mean +/- SD 3.1 +/- 2.1 3.4 +/- 2.3 
P-value 0.33 
 
 In the RCT conducted by Gustafson et al.,6 research assistants assigned 60 women aged 
18-39 to their respective groups using a computer generated 1:1 randomization, concealed to 
clinical investigators until the intervention occurred. There are much more specific inclusion and 
exclusion criteria than in the Gillier et al.5 study, which are discussed in Table 1, but most 
notably the inclusion of advance scheduled cesarean deliveries of singleton gestation carried to at 
least 39 weeks.6 An intention-to-treat analysis was performed on the 56 patients that completed 
the allocated intervention, 29 in the binder group and 27 in the control group.6 Four other 
participants were excluded from results analysis.6 Of these, two participants in the control group 
crossed over to the binder group, one by request and one by recommendation of medical staff.6  
The primary outcome of postoperative pain was assessed using the Brief Pain Inventory- 
Short Form at 24 hours postoperatively after continuous binder use. The specific question of 
interest to this review is the average level of pain reported from 0-10, though effects of pain on 
maternal activities of daily living were also evaluated by the researchers. When comparing the 
mean +/- standard deviation, the binder group reported significantly lower pain scores,  
3.45 +/- 1.74, than the control group, 4.48 +/- 1.6 (p=0.024, Table 3).6  
Table 3: Average Pain Scores at 24 hrs Post-Op in Gustafson et al Study 




Mean +/- SD 3.45 +/- 1.74 4.48 +/- 1.6 
P-value 0.024 
 
  Tuholski, Binders for Cesarean Pain  7 
In the RCT conducted by Ghana et al.,11 178 women aged 18-35 that had uncomplicated 
non-emergent cesareans in an Iranian hospital were randomized to groups of 89 by a researcher 
masked to the experiment. This study had the most specific inclusion and exclusion criteria due 
to their research on the effects of abdominal binders on postpartum hemorrhage (Table 1). Two 
participants in total were lost from the binder group because one requested removal of binder and 
the other experienced hemorrhage.11 The data was analyzed on an intention-to-treat basis.11 
Binders were applied 2 hours after delivery and worn for 2 days, but were opened between 10pm 
and 8am.11 Pain measurements using the VAS were recorded 15 minutes before routine 
administration of pain medication, and were taken at baseline and every 6 hours for 48 hours, 
then again once on day five.11 There was no difference in the baseline pain score between 
groups, yet the pain scores for patients in the binder group were significantly lower than those of 
the control group at 24 hours and all other time points (p<0.001, Table 4).11   
Table 4: Median VAS Pain Scores at 24-hours Post-Op in Ghana et al Study 




Median (Interquartile Range) 3 (3-4) 6 (6-5)a 
P-value <0.001 
a
Data reported as in original study, though it appears Q1 and Q3 may be reversed within parentheses 
 
Table 5: Adverse Events Reported in Binder Groups 
Study Binder Group Size  Adverse Event 
Gustafson et al.6 29 Itchiness (n=2)  




The strengths of the reviewed studies are their randomized controlled designs 
and implementation of a simple, inexpensive, non-pharmacologic intervention with few 
contraindications and minimal potential adverse effects.5 Additionally, valid and reliable 
measures of pain were used with straightforward statistical analysis. There were no significant 
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differences in sociodemographic variables between experimental and control groups in any 
study. All subjects who entered these trials were accounted for and attributed at their 
conclusions, with less than 5% lost to follow-up. Only three adverse events were reported (Table 
5), and no similar occurrences of hemorrhage were found in literature.11  
These studies also shared several limitations. Because of the nature of the intervention, it 
is impossible to mask the participants, researchers, and clinicians to the group allocation, 
allowing for biases to potentially influence reporting. It is notable that 17 out of 88 participants, 
or 19%, in the control group in the Gillier et al.5 study requested an abdominal binder within 6 
hours of their surgery. This implies that women may have a presumed bias towards the ability of 
the binder to reduce pain, or at least that they are interested in this potential therapy. Care 
providers may have also expressed their biases regarding binder use. Additionally, pain is a 
complex multifaceted experience; affected by psychosocial, behavioral, emotional, and 
environmental influences11 that cannot be controlled and could affect scores, particularly in small 
sample sizes.  
There are a number of discussion points that contribute to the lack of significant findings 
in the Gillier et al.5 study, perhaps because this was the first known RCT to investigate this 
particular research question. There were 28% more people in the experimental group due to high 
rates of initial dropout in control group because of inability to mask participants’ allocation.5 The 
experimenters asked participants to rate their average pain level from the last 6 hours, but there 
was no standardized time to administer the VAS on post-op day 1.5 This potentially caused 
widely varied pain scores based on the time of day and events of the previous 6 hours, including 
when the last pain medication was dispensed. Additionally, because unmeasured break time from 
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binder use was allowed, the likely variable duration of usage diminishes its power to affect 
outcomes. 
 The primary limitation in the Gustafson et al.6 study is the small sample size, but 
otherwise has several unique strengths discussed below. It is worth noting that pain interference 
with feeding the baby was lower in the binder group with results nearing significance (p=0.078) 
as measured by the modified Brief Pain Inventory- Short Form.6 The Ghana et al.11 study 
described the nightly 10 hour opening of the binder as a limitation, however it may be a strength, 
as abdominal binders are intended to reduce discomfort associated with positional changes. 
Perhaps opening the binder during a measured interval overnight allowed for improved comfort 
while sleeping and should be replicated in future studies. Other strengths in the Ghana et al.11 
study were the large equal group sizes, efforts made to conceal randomization, standardized 
times for recording pain measurements before giving medication, and comparison of baseline 
pain levels.  
Both the Gustafson et al.6 and Ghana et al.11 studies used strict inclusion criteria which may 
minimize risk of adverse events, such as non-emergent singleton gestation pregnancies delivered 
at full term. The Ghana et al.11 study further excluded smokers, those with an overweight BMI 
>25.9, and self-reported underlying disease. These are all factors known to be associated with 
increased risk of surgical complications. By standardizing the study population to generally low-
risk pregnancies in healthy women, the researchers may have been able to control for adverse 
events that could cause increased pain levels, including the emotional component of pain in cases 
of poor infant outcomes. Gustafson and colleagues found no significant between-group 
difference in the average dose of pain medication used within the first 24 hours, lending further 
validity to the significant effect of the abdominal binder on pain reduction.6  
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CONCLUSION 
Based on the objective findings of these three randomized controlled trials, there is some 
conflicting evidence as to whether or not abdominal binders placed after cesarean delivery 
reduce postoperative pain. However, given that the 2 stronger RCTs found significant evidence 
in favorable support6,11 and the remaining study is limited by many sources of variability and 
bias acknowledged by its authors,5 there is more substantial evidence to suggest yes, abdominal 
binders do reduce post-cesarean pain. The findings of these studies are not yet generalizable to 
the entire population of pregnant women undergoing cesarean deliveries because there are wide 
differences in the inclusion and exclusion criteria, and there is overall varying and limited 
evidence based on subjective data. More investigation that includes objective measures of pain 
control and addresses additional clinical implications of binder use is needed to generalize the 
answer to this question and provide evidentiary support for financing widespread implementation 
of binders. New research has already been added to the growing body of literature on this topic 
since beginning this review.    
In a 2019 quality improvement project, a work group at a Pennsylvania hospital 
implemented a comfort bundle that included abdominal binders with the intention of reducing 
opioid consumption after cesarean deliveries.4 The comfort bundle was incredibly successful, 
achieving a 61% reduction in morphine milliequivalents.4 Subsequently, a 2019 RCT reports 
“ambulation exacerbated pain in patients not wearing binders to a greater degree than in patients 
wearing binders, while statistically controlling for medication use.”1 The researchers ultimately 
supported use of abdominal binders as a safe nonpharmacologic option to provide comfort after 
cesarean birth.1 Most recently, a research hospital in Turkey published an RCT that demonstrated 
significantly reduced VAS pain levels on post-op day 1 in the binder group as well as 
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significantly increased walking distance during a 6-minute walk test in the postoperative 8th 
hour.12 None of these studies resulted in adverse events,1,4,12 and participants reported minimal to 
no discomfort1 while wearing the binder. The findings of this newly published global literature 
add support to this review’s conclusion favoring use of abdominal binders for multimodal post-
cesarean pain reduction.   
Referencing the combined strengths of these RCTs, future studies should aim to analyze 
large equal group sizes, mask group allocation as much as possible, use standardized times for 
applying the binder as well as recording pain measurements before giving analgesic medication, 
and compare baseline pain levels and dispensed morphine-equivalent doses. Experimenters 
should follow a script during recruitment to remain impartial, and they should allow set hours of 
overnight binder opening. Participants should be selected using strict inclusion criteria which 
may minimize risk of adverse events, such as non-emergent singleton gestation pregnancies 
delivered at full term. Exclusion criteria should include obesity, chronic pain, comorbidities, 
concurrent surgeries, and substance abuse. If significant results are consistently found among this 
controlled population, inclusion criteria can then be expanded and exclusion criteria minimized 
to test generalizability. Finally, future studies should use a modified Brief Pain Inventory- Short 
Form as in Gustafson et al.6 to additionally assess how much pain interferes with sleep, mood, 
walking ability, feeding, and infant bonding between binder and control groups. Measuring these 
outcomes can provide data to determine if the clinical effect of using abdominal binders for post-
cesarean pain reduction has additional implications, such as improved breast feeding rates, infant 
bonding, and ambulation during a hypercoagulable state.
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